Health Catalyst, Inc. amendment reports beneficial ownership stakes held by related reporting persons as of 03/31/2026. The filing shows Stoney Lonesome HF LP holds 6,079,539 shares (approximately 8.3%) and Drake Helix Holdings, LLC holds 227,706 shares (approximately 0.3%).
The filing states a total share count of 73,586,183 shares outstanding as of 03/05/2026 (source: issuer's Form 10-K). Related entities Coghill Capital Management, LLC and CDC Financial, Inc. are disclosed as holding or deemed to hold the combined positions, and Clint D. Coghill is identified as owning 1,100 shares directly.
Positive
None.
Negative
None.
Insights
Disclosure updates group ownership positions and voting/dispositive powers as of 03/31/2026.
The schedule amendment lists precise beneficial ownership counts: 6,079,539 shares for Stoney Lonesome and 227,706 shares for Drake Helix, with aggregated influence reflected through related entities. The filing ties percentages to a stated outstanding share base of 73,586,183 shares as of 03/05/2026.
Relevant dependencies include the group's internal relationships (general partner, managing member, sole shareholder) that create overlapping deemed ownership. Future filings or exhibits referenced (Exhibit 99.1) may clarify group classifications and any Section 13(d) implications.
Key Figures
Shares outstanding:73,586,183 sharesStoney Lonesome ownership:6,079,539 sharesStoney Lonesome percentage:8.3%+3 more
6 metrics
Shares outstanding73,586,183 sharesas of 03/05/2026 (Form 10-K)
Stoney Lonesome ownership6,079,539 sharesdirectly beneficially owned as of 03/31/2026
Stoney Lonesome percentage8.3%of outstanding shares based on 03/05/2026 share count
Drake Helix ownership227,706 sharesdirectly beneficially owned as of 03/31/2026
CDC Financial deemed ownership6,307,245 sharesdeemed beneficial owner per filing as of 03/31/2026
Clint D. Coghill direct ownership1,100 sharesdirectly beneficially owned as of 03/31/2026
"As of the close of business on March 31, 2026: (i) Stoney Lonesome directly beneficially owned 6,079,539 Shares;"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared dispositive powerregulatory
"Shared Dispositive Power 6,079,539.00"
Schedule 13G/Aregulatory
"This statement is filed by: ... Signed: /s/ Clint D. Coghill"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
What stake does Stoney Lonesome HF hold in Health Catalyst (HCAT)?
Stoney Lonesome HF directly owns 6,079,539 shares, which represents approximately 8.3% of Health Catalyst's outstanding shares based on 73,586,183 shares outstanding as of 03/05/2026.
How many shares does Drake Helix Holdings report owning in HCAT?
Drake Helix Holdings, LLC directly owns 227,706 shares, equal to about 0.3% of the issuer's 73,586,183 shares outstanding (as of 03/05/2026), per the amendment.
Does the filing show CDC Financial's beneficial ownership percentage in HCAT?
Yes. CDC Financial is deemed to beneficially own a combined 6,307,245 shares, representing approximately 8.6% of the outstanding shares using the 03/05/2026 share base disclosed in the Form 10-K.
How much does Clint D. Coghill directly own in Health Catalyst (HCAT)?
Clint D. Coghill directly owns 1,100 shares of common stock, as reported in the Schedule 13G/A amendment dated 03/31/2026 and signed on 05/15/2026.
What is the reference share count used to calculate these percentages for HCAT?
The percentages use a reported total of 73,586,183 shares outstanding as of 03/05/2026, disclosed in the issuer's Annual Report on Form 10-K filed on 03/12/2026.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)
Health Catalyst, Inc.
(Name of Issuer)
Common Stock, par value $0.001 per share
(Title of Class of Securities)
42225T107
(CUSIP Number)
03/31/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
42225T107
1
Names of Reporting Persons
Stoney Lonesome HF LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
6,079,539.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
6,079,539.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
6,079,539.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
8.3 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP Number(s):
42225T107
1
Names of Reporting Persons
COGHILL CAPITAL MANAGEMENT LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
6,079,539.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
6,079,539.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
6,079,539.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
8.3 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP Number(s):
42225T107
1
Names of Reporting Persons
Drake Helix Holdings, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
WYOMING
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
227,706.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
227,706.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
227,706.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0.3 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP Number(s):
42225T107
1
Names of Reporting Persons
CDC Financial, Inc.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
ILLINOIS
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
6,307,245.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
6,307,245.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
6,307,245.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
8.6 %
12
Type of Reporting Person (See Instructions)
CO
SCHEDULE 13G
CUSIP Number(s):
42225T107
1
Names of Reporting Persons
COGHILL CLINT D
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
1,100.00
6
Shared Voting Power
6,307,245.00
7
Sole Dispositive Power
1,100.00
8
Shared Dispositive Power
6,307,245.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
6,308,345.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
8.6 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Health Catalyst, Inc.
(b)
Address of issuer's principal executive offices:
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN, UT, 84095
Item 2.
(a)
Name of person filing:
This statement is filed by:
(i) Stoney Lonesome HF LP, a Delaware limited partnership ("Stoney Lonesome"), with respect to the shares of Common Stock, par value $0.001 per share, of the Issuer (the "Shares") directly and beneficially owned by it;
(ii) Coghill Capital Management, LLC, a Delaware limited liability company ("CCM"), as the general partner of Stoney Lonesome;
(iii) The Drake Helix Holdings, LLC, a Wyoming limited liability company ("Drake Helix"), with respect to the Shares directly and beneficially owned by it;
(iv) CDC Financial, Inc., an Illinois corporation ("CDC Financial"), as the managing member of each of CCM and Drake Helix; and
(v) Clint D. Coghill, with respect to the Shares directly and beneficially owned by him and as the President and sole shareholder of CDC Financial.
Each of the foregoing is referred to as a "Reporting Person" and collectively as the "Reporting Persons."
(b)
Address or principal business office or, if none, residence:
The principal business address of each of the Reporting Persons is 222 S Riverside Plaza, 15th Floor, Chicago, Illinois 60606.
(c)
Citizenship:
Each of Stoney Lonesome and CCM is organized under the laws of the State of Delaware. Drake Helix is organized under the laws of the State of Wyoming. CDC Financial is organized under the laws of the State of Illinois. Mr. Coghill is a citizen of the United States of America.
(d)
Title of class of securities:
Common Stock, par value $0.001 per share
(e)
CUSIP No.:
42225T107
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
As of the close of business on March 31, 2026:
(i) Stoney Lonesome directly beneficially owned 6,079,539 Shares;
(ii) CCM, as the general partner of Stoney Lonesome, may be deemed the beneficial owner of the 6,079,539 Shares directly beneficially owned by Stoney Lonesome;
(iii) Drake Helix directly beneficially owned 227,706 Shares;
(iv) CDC Financial, as the managing member of each of CCM and Drake Helix, may be deemed the beneficial owner of the 6,079,539 Shares directly beneficially owned by Stoney Lonesome and the 227,706 Shares directly beneficially owned by Drake Helix; and
(v) Mr. Coghill directly beneficially owned 1,100 Shares. As the President and sole shareholder of CDC Financial, Mr. Coghill may also be deemed the beneficial owner of the 6,079,539 Shares directly beneficially owned by Stoney Lonesome and the 227,706 Shares directly beneficially owned by Drake Helix.
The filing of this Schedule 13G shall not be deemed an admission that the Reporting Persons are, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, the beneficial owners of any securities of the Issuer that such Reporting Person does not directly own. Each of the Reporting Persons specifically disclaims beneficial ownership of the securities reported herein that he or it does not directly own.
(b)
Percent of class:
The following percentages are based on 73,586,183 Shares outstanding as of March 5, 2026, which is the total number of Shares outstanding as disclosed in the Issuer's Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 12, 2026.
As of the close of business on March 31, 2026, (i) Stoney Lonesome beneficially owned approximately 8.3% of the outstanding Shares, (ii) CCM may be deemed to beneficially own approximately 8.3% of the outstanding Shares, (iii) Drake Helix beneficially owned approximately 0.3% of the outstanding Shares, (iv) CDC Financial may be deemed to beneficially own approximately 8.6% of the outstanding Shares and (v) Mr. Coghill may be deemed to beneficially own approximately 8.6% of the outstanding Shares.
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
See Cover Pages Items 5-9.
(ii) Shared power to vote or to direct the vote:
See Cover Pages Items 5-9.
(iii) Sole power to dispose or to direct the disposition of:
See Cover Pages Items 5-9.
(iv) Shared power to dispose or to direct the disposition of:
See Cover Pages Items 5-9.
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group.
See Exhibit 99.1 to the Schedule 13G filed by the Reporting Persons with the Securities and Exchange Commission on December 22, 2025.
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Stoney Lonesome HF LP
Signature:
/s/ Clint D. Coghill
Name/Title:
Clint D. Coghill, President and sole shareholder of the managing member of its general partner
Date:
05/15/2026
COGHILL CAPITAL MANAGEMENT LLC
Signature:
/s/ Clint D. Coghill
Name/Title:
Clint D. Coghill, President and sole shareholder of its managing member
Date:
05/15/2026
Drake Helix Holdings, LLC
Signature:
/s/ Clint D. Coghill
Name/Title:
Clint D. Coghill, President and sole shareholder of its managing member
